What is Cetylite?
Cetylite, Inc. operates as a specialized manufacturer and distributor of high-performance dental and medical products. The firm is recognized for its focus on patient-centric healthcare solutions, most notably its proprietary Cetacaine line, which has become a staple in dental practices for enhancing patient comfort. Beyond dental applications, the company maintains a strong portfolio of Rx and disinfection products designed to meet the rigorous safety and sterilization standards required in modern clinical environments. By bridging the gap between clinical efficacy and patient satisfaction, Cetylite has established itself as a critical partner for healthcare professionals seeking reliable, high-quality medical supplies.
How much funding has Cetylite raised?
Cetylite has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Cetylite
PPP
Public-Private Partnership
What's next for Cetylite?
With the successful acquisition of this late-stage capital, Cetylite is well-positioned to accelerate its operational growth and deepen its market penetration. The strategic deployment of these funds will likely focus on scaling manufacturing capabilities to meet rising demand for its disinfection and sterilization solutions. Furthermore, the company is expected to leverage this financial backing to enhance its research and development pipeline, potentially introducing new proprietary formulations that address evolving safety protocols in the medical field. As the healthcare industry continues to prioritize infection control and patient experience, Cetylite's focus on specialized, high-margin products provides a clear competitive advantage for long-term value creation.
See full Cetylite company page
